214 related articles for article (PubMed ID: 2525351)
1. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
[TBL] [Abstract][Full Text] [Related]
2. [Enoximone, a new phosphodiesterase inhibitor: the spectrum of applications during heart surgery--a comparison with dobutamine].
Boldt J; Kling D; Schuhmann E; Scheld HH; Hempelmann G
Herz; 1988 Oct; 13(5):335-42. PubMed ID: 2972597
[TBL] [Abstract][Full Text] [Related]
3. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamic effects of the phosphodiesterase inhibitor enoximone during exposure to the volatile anesthetics halothane and isoflurane in coronary surgery patients].
Molter G; Larsen R; Peters U; Bauch U; Sefrin R
Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Dec; 28(8):493-9. PubMed ID: 8292702
[TBL] [Abstract][Full Text] [Related]
5. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
[TBL] [Abstract][Full Text] [Related]
6. [Meptazinol, a new analgesic. Hemodynamic and respiratory effects].
Boldt J; Kling D; von Bormann B; Knoblauch K; Görlach G; Hempelmann G
Anaesthesist; 1987 Nov; 36(11):622-8. PubMed ID: 3322096
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of new cardiac agents using differential therapeutic criteria].
Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
[TBL] [Abstract][Full Text] [Related]
8. [The effectiveness of enoximone in patients with serious left ventricular dysfunction submitted for aorto-coronary bypass].
Oppizzi M; Montorsi E; Tosoni A; Casati V; Venturino M; Franco A; Gerli C; Paolillo G
Minerva Anestesiol; 1997; 63(1-2):17-27. PubMed ID: 9213836
[TBL] [Abstract][Full Text] [Related]
9. Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease.
Stephan H; Kazmaier S; Hoeft A; Sonntag H
Anesth Analg; 1994 Dec; 79(6):1059-65. PubMed ID: 7978427
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of enoximone in cardiac surgery patients.
Boldt J; Dieterich HA; Kling D; Hempelmann G
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S50-6. PubMed ID: 2480486
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic changes following the injection of lormetazepam under premedication and anesthesia conditions in coronary surgery patients].
Kling D; von Bormann B; Scheld HH; Kramer M; Hempelmann G
Anasth Intensivther Notfallmed; 1983 Dec; 18(6):296-300. PubMed ID: 6666843
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
Boldt J; Hempelmann G
Z Kardiol; 1991; 80 Suppl 4():41-6. PubMed ID: 1833896
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
[TBL] [Abstract][Full Text] [Related]
14. Effects of dobutamine and enoximone on transmitral and pulmonary venous flow characteristics in patients with left ventricular dysfunction after coronary artery bypass grafting.
Vroom MB; van Wezel HB; vd Brink RB; vd Lee R; Eijsman L; Visser CA; van Zwieten PA
J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):756-63. PubMed ID: 8910155
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
[TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic response to intravenous enoximone: an animal study and preliminary report in infants after cardiac surgery.
Schranz D; Huth R; Dahm M; Iversen S; Hein E; Stopfkuchen H; Jüngst BK
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S62-8. PubMed ID: 2480488
[TBL] [Abstract][Full Text] [Related]
17. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G
Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
[TBL] [Abstract][Full Text] [Related]
18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
19. Effects of enoximone on right-ventricular function in patients with impaired myocardial performance.
Petry A; Dütschke P; Regensburger D
Thorac Cardiovasc Surg; 1996 Aug; 44(4):173-7. PubMed ID: 8896158
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the effects of 'inodilators' on the myocardium in patients without primary cardiac insufficiency after coronary surgery: Part II--Enoximone.
Redmann K; Lunkenheimer PP; Isringhaus H; Geiger A; Rettig G; Flameng W; Demeyre T; Engel C; Peterschmidt O
Thorac Cardiovasc Surg; 1991 Jun; 39(3):129-32. PubMed ID: 1831936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
